Q1 2012 Earnings Call
April 26, 2012 9:00 am ET
Eric Rojas - Director of Investor Relations - North America
Angus C. Russell - Chief Executive Officer and Executive Director
Sylvie Gregoire - President of Human Genetic Therapies Business and Member of Management Committee
Graham Hetherington - Chief Financial Officer, Principal Accounting Officer and Director
Jeff Jonas - Senior Vice President of Research & Development for Pharmaceuticals Business
Gary Nachman - Susquehanna Financial Group, LLLP, Research Division
Brian White - Shore Capital Group Ltd., Research Division
David M. Steinberg - Deutsche Bank AG, Research Division
Graham Parry - BofA Merrill Lynch, Research Division
David Amsellem - Piper Jaffray Companies, Research Division
Keyur Parekh - Goldman Sachs Group Inc., Research Division
Good day, ladies and gentlemen, and welcome to the Shire's 2012 First Quarter Results Call hosted by Eric Rojas. My name is Jo, and I'm your event manager today. [Operator Instructions] I would like to advise all parties that this conference is being recorded for replay purposes.
And I would like to hand the call over to your host, Eric. Please go ahead.
Thanks, Jo. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's First Quarter 2012 Financial Results. By now, you should have all received our press release and should be viewing our presentation via our website on shire.com. If for some reason you have not received the press release or are unable to access our website, please contact Souheil Salah in our U.K. Investor Relations department at +44-1256-894-160, and he will be happy to assist you.